Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
Condition(s):LymphomaLast Updated:December 13, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:December 13, 2019Terminated
Condition(s):Injection Site ReactionLast Updated:February 15, 2019Completed
Condition(s):HealthyLast Updated:December 6, 2017Completed
Condition(s):Trauma; Surgery; Deep Vein Thrombosis (DVT); Thromboembolic EventsLast Updated:November 13, 2023Recruiting
Condition(s):Deep Vein Thrombosis; Venous ThromboembolismLast Updated:January 18, 2020Unknown status
Condition(s):BruisesLast Updated:March 10, 2009Completed
Condition(s):Acute Coronary Syndrome; Factor XLast Updated:November 3, 2015Completed
Condition(s):Safety Issues; Effect of DrugLast Updated:November 2, 2023Recruiting
Condition(s):Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer SurgeryLast Updated:January 23, 2024Not yet recruiting
Condition(s):ThromboembolismLast Updated:July 2, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.